Tiffany Harris‐Brown

1.4k total citations
15 papers, 183 citations indexed

About

Tiffany Harris‐Brown is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Epidemiology. According to data from OpenAlex, Tiffany Harris‐Brown has authored 15 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Applied Microbiology and Biotechnology and 5 papers in Epidemiology. Recurrent topics in Tiffany Harris‐Brown's work include Antibiotic Use and Resistance (6 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Microscopic Colitis (4 papers). Tiffany Harris‐Brown is often cited by papers focused on Antibiotic Use and Resistance (6 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Microscopic Colitis (4 papers). Tiffany Harris‐Brown collaborates with scholars based in Australia, Singapore and United Kingdom. Tiffany Harris‐Brown's co-authors include David L. Paterson, Luis Furuya‐Kanamori, Patrick N. A. Harris, Archie C. A. Clements, Charlotte Huber, Thomas V. Riley, Eugene Athan, Jonathan R. Iredell, Spiros Miyakis and Andrew J. Stewardson and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Microbiology and Journal of Medical Internet Research.

In The Last Decade

Tiffany Harris‐Brown

12 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tiffany Harris‐Brown Australia 7 62 57 53 50 36 15 183
Alvaro Quintana United States 10 95 1.5× 48 0.8× 61 1.2× 51 1.0× 88 2.4× 28 221
Verónica Pérez-Blanco Spain 9 164 2.6× 37 0.6× 35 0.7× 36 0.7× 41 1.1× 18 251
Zaira R. Palacios‐Baena Spain 9 108 1.7× 75 1.3× 76 1.4× 65 1.3× 50 1.4× 28 262
Arsim Kurti Kosovo 8 50 0.8× 54 0.9× 59 1.1× 86 1.7× 7 0.2× 15 192
Judith Hackett United States 7 50 0.8× 56 1.0× 32 0.6× 138 2.8× 20 0.6× 16 248
Morgan Matt France 9 40 0.6× 85 1.5× 38 0.7× 59 1.2× 24 0.7× 20 214
Zeynep Türe Türkiye 8 27 0.4× 105 1.8× 29 0.5× 67 1.3× 17 0.5× 50 220
Avnish Sandhu United States 6 30 0.5× 39 0.7× 34 0.6× 35 0.7× 12 0.3× 12 125
Maryrose Laguio‐Vila United States 8 15 0.2× 66 1.2× 28 0.5× 69 1.4× 41 1.1× 29 229
Tomer Ziv Israel 5 29 0.5× 42 0.7× 25 0.5× 23 0.5× 14 0.4× 7 146

Countries citing papers authored by Tiffany Harris‐Brown

Since Specialization
Citations

This map shows the geographic impact of Tiffany Harris‐Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffany Harris‐Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffany Harris‐Brown more than expected).

Fields of papers citing papers by Tiffany Harris‐Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiffany Harris‐Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffany Harris‐Brown. The network helps show where Tiffany Harris‐Brown may publish in the future.

Co-authorship network of co-authors of Tiffany Harris‐Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Tiffany Harris‐Brown. A scholar is included among the top collaborators of Tiffany Harris‐Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffany Harris‐Brown. Tiffany Harris‐Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Teede, Helena, Karen P Best, Frank H. Bloomfield, et al.. (2024). Implementability and impact in clinical research and the role of clinical trial networks. The Medical Journal of Australia. 221(8). 410–413.
2.
Stewart, Adam G., Patrick N. A. Harris, Rikki Graham, et al.. (2024). Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trial. Pathology. 56. S36–S37. 1 indexed citations
3.
Stewart, Adam G., Sharon C.-A. Chen, Kate Hamilton, et al.. (2023). Clostridioides difficileInfection: Clinical Practice and Health Outcomes in 6 Large Tertiary Hospitals in Eastern Australia. Open Forum Infectious Diseases. 10(6). ofad232–ofad232.
4.
Peel, Trisha, Allen Cheng, David L. Paterson, et al.. (2023). MULTICENTRE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF COMBINATION VANCOMYCIN AND CEFAZOLIN SURGICAL ANTIBIOTIC PROPHYLAXIS IN ARTHROPLASTY SURGERY. Orthopaedic Proceedings. 105-B(SUPP_12). 21–21.
5.
Peel, Trisha, Allen Cheng, David L. Paterson, et al.. (2023). Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty. New England Journal of Medicine. 389(16). 1488–1498. 30 indexed citations
6.
7.
McCarthy, Kate, et al.. (2021). The MOBILISE study: utilisation of ambulatory pumps in the inpatient setting to administer continuous antibiotic infusions—a randomised controlled trial. European Journal of Clinical Microbiology & Infectious Diseases. 40(12). 2505–2513. 1 indexed citations
8.
Stewart, Alastair G., David L. Paterson, Barnaby Edward Young, et al.. (2021). Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2). 2 indexed citations
9.
Furuya‐Kanamori, Luis, Archie C. A. Clements, Charlotte Huber, et al.. (2016). Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012–2014: prospective, repeated cross-sectional study. Clinical Microbiology and Infection. 23(1). 48.e1–48.e7. 26 indexed citations
10.
Furuya‐Kanamori, Luis, Thomas V. Riley, David L. Paterson, et al.. (2016). Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities. Journal of Clinical Microbiology. 55(1). 216–225. 22 indexed citations
11.
Harris‐Brown, Tiffany & David L. Paterson. (2015). Reporting of pre-enrolment screening with randomized clinical trials: A small item that could impact a big difference. Perspectives in Clinical Research. 6(3). 139–139. 6 indexed citations
12.
Paterson, David L., T. V. Riley, Charlotte Huber, et al.. (2015). Prevalence of asymptomatic Clostridium difficile colonization in tertiary hospital patients in Australia. Antimicrobial Resistance and Infection Control. 4(S1). 1 indexed citations
13.
14.
Zowawi, Hosam M., Malak Abedalthagafi, Tiffany Harris‐Brown, et al.. (2015). The Potential Role of Social Media Platforms in Community Awareness of Antibiotic Use in the Gulf Cooperation Council States: Luxury or Necessity?. Journal of Medical Internet Research. 17(10). e233–e233. 31 indexed citations
15.
Rogers, Benjamin A., et al.. (2014). Predictors of use of infection control precautions for multiresistant gram-negative bacilli in Australian hospitals: Analysis of a national survey. American Journal of Infection Control. 42(9). 963–969. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alvaro Quintana Breakdown of academic impact, for papers by Verónica Pérez-Blanco Breakdown of academic impact, for papers by Zaira R. Palacios‐Baena Breakdown of academic impact, for papers by Arsim Kurti Breakdown of academic impact, for papers by Judith Hackett Breakdown of academic impact, for papers by Morgan Matt Breakdown of academic impact, for papers by Zeynep Türe Breakdown of academic impact, for papers by Avnish Sandhu Breakdown of academic impact, for papers by Maryrose Laguio‐Vila Breakdown of academic impact, for papers by Tomer Ziv
Rankless by CCL
2026